130 related articles for article (PubMed ID: 38588613)
21. Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer.
Lipkin SM; Chao EC; Moreno V; Rozek LS; Rennert H; Pinchev M; Dizon D; Rennert G; Kopelovich L; Gruber SB
Cancer Prev Res (Phila); 2010 May; 3(5):597-603. PubMed ID: 20403997
[TBL] [Abstract][Full Text] [Related]
22. Statin resistance in Candida glabrata.
Subhan M; Faryal R; Macreadie I
Biotechnol Lett; 2018 Oct; 40(9-10):1389-1394. PubMed ID: 30054755
[TBL] [Abstract][Full Text] [Related]
23. Degradation versus Inhibition: Development of Proteolysis-Targeting Chimeras for Overcoming Statin-Induced Compensatory Upregulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase.
Li MX; Yang Y; Zhao Q; Wu Y; Song L; Yang H; He M; Gao H; Song BL; Luo J; Rao Y
J Med Chem; 2020 May; 63(9):4908-4928. PubMed ID: 32321253
[TBL] [Abstract][Full Text] [Related]
24. The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins.
Mo H; Jeter R; Bachmann A; Yount ST; Shen CL; Yeganehjoo H
Front Pharmacol; 2018; 9():1515. PubMed ID: 30662405
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death.
Pandyra AA; Mullen PJ; Goard CA; Ericson E; Sharma P; Kalkat M; Yu R; Pong JT; Brown KR; Hart T; Gebbia M; Lang KS; Giaever G; Nislow C; Moffat J; Penn LZ
Oncotarget; 2015 Sep; 6(29):26909-21. PubMed ID: 26353928
[TBL] [Abstract][Full Text] [Related]
26. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
Hoque A; Chen H; Xu XC
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
[TBL] [Abstract][Full Text] [Related]
27. Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain.
Chen H; Qi X; Faulkner RA; Schumacher MM; Donnelly LM; DeBose-Boyd RA; Li X
Nat Commun; 2022 Jul; 13(1):4273. PubMed ID: 35879350
[TBL] [Abstract][Full Text] [Related]
28. The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer.
Bhardwaj A; Singh H; Trinidad CM; Albarracin CT; Hunt KK; Bedrosian I
Breast Cancer Res; 2018 Dec; 20(1):150. PubMed ID: 30537987
[TBL] [Abstract][Full Text] [Related]
29. Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells.
Wong DH; Villanueva JA; Cress AB; Sokalska A; Ortega I; Duleba AJ
Fertil Steril; 2011 Nov; 96(5):1252-8. PubMed ID: 21907337
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of human 3-hydroxy-3-methylglutaryl CoA reductase by peptides leading to cholesterol homeostasis through SREBP2 pathway in HepG2 cells.
Kumar V; Sharma P; Bairagya HR; Sharma S; Singh TP; Tiku PK
Biochim Biophys Acta Proteins Proteom; 2019 Jun; 1867(6):604-615. PubMed ID: 30954578
[TBL] [Abstract][Full Text] [Related]
31. Human hydroxymethylglutaryl-coenzyme A reductase (HMGCR) and statin sensitivity.
Jawaid S; Gertz M; Corsino C; Cheung J; Seidle H; Couch RD
Indian J Biochem Biophys; 2010 Dec; 47(6):331-9. PubMed ID: 21355415
[TBL] [Abstract][Full Text] [Related]
32. Immediate utility of two approved agents to target both the metabolic mevalonate pathway and its restorative feedback loop.
Pandyra A; Mullen PJ; Kalkat M; Yu R; Pong JT; Li Z; Trudel S; Lang KS; Minden MD; Schimmer AD; Penn LZ
Cancer Res; 2014 Sep; 74(17):4772-82. PubMed ID: 24994712
[TBL] [Abstract][Full Text] [Related]
33. Rapid proteasomal elimination of 3-hydroxy-3-methylglutaryl-CoA reductase by interferon-γ in primary macrophages requires endogenous 25-hydroxycholesterol synthesis.
Lu H; Talbot S; Robertson KA; Watterson S; Forster T; Roy D; Ghazal P
Steroids; 2015 Jul; 99(Pt B):219-29. PubMed ID: 25759117
[TBL] [Abstract][Full Text] [Related]
34. The role of HMGCR alternative splicing in statin efficacy.
Medina MW; Krauss RM
Trends Cardiovasc Med; 2009 Jul; 19(5):173-7. PubMed ID: 20005478
[TBL] [Abstract][Full Text] [Related]
35. The relationship between HMGCR genetic variation, alternative splicing, and statin efficacy.
Medina MW
Discov Med; 2010 Jun; 9(49):495-9. PubMed ID: 20587337
[TBL] [Abstract][Full Text] [Related]
36. Statins and prostate cancer-hype or hope? The biological perspective.
Longo J; Freedland SJ; Penn LZ; Hamilton RJ
Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):650-656. PubMed ID: 35768578
[TBL] [Abstract][Full Text] [Related]
37. Characterization of peroxisomal 3-hydroxy-3-methylglutaryl coenzyme A reductase in UT2 cells: sterol biosynthesis, phosphorylation, degradation, and statin inhibition.
Aboushadi N; Shackelford JE; Jessani N; Gentile A; Krisans SK
Biochemistry; 2000 Jan; 39(1):237-47. PubMed ID: 10625499
[TBL] [Abstract][Full Text] [Related]
38. Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl-CoA reductase activity and mRNA abundance in the guinea pig.
Conde K; Roy S; Freake HC; Newton RS; Fernandez ML
Lipids; 1999 Dec; 34(12):1327-32. PubMed ID: 10652993
[TBL] [Abstract][Full Text] [Related]
39. Hypocholesterolemic effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in the guinea pig: atorvastatin versus simvastatin.
Conde K; Pineda G; Newton RS; Fernandez ML
Biochem Pharmacol; 1999 Oct; 58(7):1209-19. PubMed ID: 10484079
[TBL] [Abstract][Full Text] [Related]
40. Direct binding to sterols accelerates endoplasmic reticulum-associated degradation of HMG CoA reductase.
Faulkner RA; Yang Y; Tsien J; Qin T; DeBose-Boyd RA
Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2318822121. PubMed ID: 38319967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
